Barešić, M., Novak, S., Perković, D., Karanović, B., Mirić, F., Radić, M. & Anić, B. (2023). Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study. Clinical Rheumatology, 42. (10), 2897-2903. doi: 10.1007/s10067-023-06689-3
Barešić, Marko, et al. "Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study." Clinical Rheumatology, vol. 42, no. 10, 2023, pp. 2897-2903. https://doi.org/10.1007/s10067-023-06689-3
Barešić, Marko, Srđan Novak, Dijana Perković, Boris Karanović, Filip Mirić, Mislav Radić and Branimir Anić. "Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study." Clinical Rheumatology 42, no. 10 (2023): 2897-2903. https://doi.org/10.1007/s10067-023-06689-3
Barešić, M., et al. (2023) 'Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study', Clinical Rheumatology, 42(10), pp. 2897-2903. doi: 10.1007/s10067-023-06689-3
Barešić M, Novak S, Perković D, Karanović B, Mirić F, Radić M, and sur.. Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study. Clinical Rheumatology [Internet]. 2023 July 01 [cited 2024 September 30];42(10):2897-2903. doi: 10.1007/s10067-023-06689-3
M. Barešić, et al., "Real world experience with nintedanib in connective tissue disease-related interstitial lung disease: a retrospective cohort study", Clinical Rheumatology, vol. 42, no. 10, pp. 2897-2903, July 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:915647. [Accessed: 30 September 2024]